A case of ovarian hyperstimulation syndrome associated with the methylenetetrahydrofolate reductase mutation gene

Fertility and Sterility

Volumn 84, Issue 1, 2005, Pages 218.e17-218.e18

  Ferrara, Filippo ^a,b   Meli, Francesco ^a   Amato, Corrado ^a   Cospite, Valentina ^a   Raimondi, Francesco ^a   Novo, Salvatore ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b NONE   (Italy)

Author keywords

Methylenetetrahydrofolate reductase gene 677T homozygosis mutation; Methylenetetrahydrofolate reductase gene A1298C heterozygosis mutation; Ovarian hyperstimulation syndrome

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; NADROPARIN; PYRIDOXINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ADULT; ARTICLE; BIRTH; CASE REPORT; DELIVERY; FEMALE; FETUS; FOLLOW UP; GENE MUTATION; GENETIC ASSOCIATION; HEALTH STATUS; HETEROZYGOSITY; HOMOZYGOSITY; HOSPITAL; HUMAN; OVARY DISEASE; PATHOGENESIS; PRIORITY JOURNAL; ENZYMOLOGY; GENETICS; MUTATION; OVARY HYPERSTIMULATION; PREGNANCY; PREGNANCY COMPLICATION;

ADULT; FEMALE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION; OVARIAN HYPERSTIMULATION SYNDROME; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 22244446521     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2005.01.108     Document Type: Article

References (9)

1. J.R. Lioret de Mola, R. Kiwi, C. Austin, J.M. Goldfarb Subclavian deep vein thrombosis associated with the use of recombinant follicle-stimulating hormone (Gonal-F) complicating mild ovarian hyperstimulation syndrome Fertil Stertil 73 2000 1253 1256
2. E. Tacvmergen, H.T. Ozcakir, R. Levi, F. Adakan, M. Ulukus, M.C. Terek Bilateral jugular vein thromboembolism and pulmonary emboli in a patient with severe ovarian hyperstimulation syndrome J Obstet Gynaecol Res 27 2001 217 220
3. M. Dulitzky, S.B. Cohen, A. Inbal, D.S. Seidman, D. Soriano, A. Lidor Increased prevalence of thrombophilia among women with severe ovarian hyperstimulation syndrome Fertil Steril 77 2002 463 467
4. A. Szeklik, M. Sanak, M. Jankowski, J. Dropoinski, R. Czachor, J. Musial Mutation A1298C of methylentetraidrofolate reductase risk for early coronary disease not associated with hyperhomocysteinemia Am J Genet 101 2001 36 39
5. R. Castro, I. Rivera, P. Ravasco, C. Jakobs, H.J. Blom, M.E. Camilo 5,10-Methylentetrahydrofolate reductase 677→T and 1298→C mutation are genetic determinants of elevated homocysteine Q J Med 95 2003 1517 1532
6. Z. Chen, A.C. Karaplis, S.L. Ackerman, I.P. Pogribny, S. Melnyk, S. Lussier-Cacan Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition Hum Mol Genet 10 2001 433 443
7. P. Mercie, O. Garnier, L. Lascoste, M. Renard, C. Closse, F. Durrieu Homocysteine-thiolactone induces caspase-independent vascular endothelial cell death with apoptotic feature Apoptosis 5 2000 403 411
8. B. Horstlkamp, M. Lubke, H. Kentenich, U. Buscher, W. Licthnegger Internal jugular vein thrombosis caused by resistance to activated protein C as a complication of ovarian hyperstimulation after in-vitro fertilization Hum Reprod 11 1996 280 282
9. J. Curvers, S.J. Nienhuis, A.W. Nap, K. Hamulyak, J.L. Evers, J. Rosing Activated protein C resistance during in vitro fertilization treatment Eur J Obstet Reprod Biol 95 2001 222 224